moxifloxacin has been researched along with Nasal Catarrh in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arvis, P; Desrosiers, M; Heldner, S; Mösges, R | 1 |
| Edzhe, MA; Hon, EM; Korostelev, SA; Miroshnichenko, NA; Ovchinnikov, AY | 1 |
| Hu, B; Jiang, X; Liang, C; Ruan, B; Wang, H; Wang, J; Xiao, G; Xiao, S; Ye, Q; Zhai, L; Zhou, B | 1 |
| Desrosiers, M; Hadley, JA; Haverstock, D; Herman-Gnjidic, Z; Mösges, R; van Veenhuyzen, D | 1 |
| Dinis, PB; Martins, ML; Monteiro, MC; Morais, JG; Silva, N | 1 |
| Ferguson, BJ; Guzzetta, RV; Hadley, JA; Spector, SL | 1 |
| Anon, JB | 1 |
| Blair, C; Kirtsreesakul, V; Luxameechanporn, T; Naclerio, RM; Thompson, K | 1 |
| Chuchueva, NG; Ivanchenko, OA; Lopatin, AS | 1 |
2 review(s) available for moxifloxacin and Nasal Catarrh
| Article | Year |
|---|---|
[15-year experience of moxifloxacin in the treatment of patients with bacterial rhinosinusitis].
Topics: Acute Disease; Anti-Bacterial Agents; Bacterial Infections; Fluoroquinolones; Humans; Moxifloxacin; Rhinitis; Russia; Sinusitis; Treatment Outcome | 2015 |
Current management of acute bacterial rhinosinusitis and the role of moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Levofloxacin; Meta-Analysis as Topic; Moxifloxacin; Ofloxacin; Practice Guidelines as Topic; Quinolines; Rhinitis; Sinusitis; Streptococcus pneumoniae | 2005 |
5 trial(s) available for moxifloxacin and Nasal Catarrh
| Article | Year |
|---|---|
Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study.
Topics: Activities of Daily Living; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Aza Compounds; Child; Child, Preschool; Europe; Female; Fluoroquinolones; Humans; Infant; Male; Middle Aged; Middle East; Moxifloxacin; Prospective Studies; Quinolines; Rhinitis; Sinusitis; Sleep; Treatment Outcome | 2013 |
Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Product Surveillance, Postmarketing; Prospective Studies; Quinolines; Rhinitis; Sinusitis; Treatment Outcome; Young Adult | 2010 |
Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Patient Dropouts; Quinolines; Rhinitis; Sinusitis; Treatment Outcome | 2010 |
Sinus tissue concentration of moxifloxacin after a single oral dose.
Topics: Administration, Oral; Adult; Age Factors; Aged; Anti-Infective Agents; Aza Compounds; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Nasal Mucosa; Paranasal Sinuses; Quinolines; Rhinitis; Sinusitis | 2004 |
Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aza Compounds; Bacterial Infections; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Ketolides; Macrolides; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Rhinitis; Sinusitis; Time Factors | 2004 |
2 other study(ies) available for moxifloxacin and Nasal Catarrh
| Article | Year |
|---|---|
The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Aza Compounds; Azithromycin; CD11b Antigen; CD4 Antigens; CD8 Antigens; Disease Models, Animal; Female; Fluoroquinolones; Male; Mice; Mice, Inbred C57BL; Moxifloxacin; Pneumococcal Infections; Quinolines; Rhinitis; Sinusitis; Streptococcus pneumoniae | 2006 |
[Avelox efficacy in the treatment of acute purulent rhinosinusitis].
Topics: Acute Disease; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Moxifloxacin; Quinolines; Rhinitis; Suppuration; Tomography, X-Ray Computed; Treatment Outcome | 2007 |